Live thread

Moderna and CEPI accelerate Bundibugyo Ebola vaccine development amid DR Congo outbreak 2026

The vaccine alliance CEPI and Moderna are accelerating the development of three vaccine candidates against Bundibugyo Ebolavirus. With a funding commitment of $62 million, the vaccines are to enter clinical trials faster in light of over 900 suspected cases in the Democratic Republic of Congo.

This story is part of Kirla. Sign in to read the full coverage.

Sign in to read